To test the involvement of p53 in microcephaly, Duke postdoctoral fellow John McMahon suppressed it in each of the three types of mice. By blocking p53 at a crucial point in development, the team was able to trigger the brains to partially or fully recover to normal size, suggesting that p53 or its signaling partners might be considered as new therapeutic targets for microcephaly.